摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-amino-6-bromo-4-(1-cyano-2-methoxy-2-oxoethyl)-8-methoxy-4H-chromene-3-carboxylate

中文名称
——
中文别名
——
英文名称
methyl 2-amino-6-bromo-4-(1-cyano-2-methoxy-2-oxoethyl)-8-methoxy-4H-chromene-3-carboxylate
英文别名
——
methyl 2-amino-6-bromo-4-(1-cyano-2-methoxy-2-oxoethyl)-8-methoxy-4H-chromene-3-carboxylate化学式
CAS
——
化学式
C16H15BrN2O6
mdl
——
分子量
411.209
InChiKey
LGMMIYFVDIELPJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    25
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    121
  • 氢给体数:
    1
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    5-溴-2-羟基-3-甲氧基苯甲醛氰乙酸甲酯 在 potassium zirconium orthophosphate 作用下, 反应 1.0h, 以92%的产率得到methyl 2-amino-6-bromo-4-(1-cyano-2-methoxy-2-oxoethyl)-8-methoxy-4H-chromene-3-carboxylate
    参考文献:
    名称:
    Potassium exchanged layered zirconium phosphate as catalyst in the preparation of 4H-chromenes
    摘要:
    Substituted 4H-chromenes were easily prepared by reaction of salicylaldehydes and ethylcyanoacetate in solvent free conditions using potassium exchanged layered zirconium phosphate as catalyst. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2005.03.075
点击查看最新优质反应信息

文献信息

  • Chemical entities that kill senescent cells for use in treating age-related disease
    申请人:Unity Biotechnology, Inc.
    公开号:US10195213B2
    公开(公告)日:2019-02-05
    Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.
    本文公开的化合物可有效治疗与衰老有关的各种疾病状态。所公开的化合物可用于消除衰老细胞以治疗疾病。化合物的给药方式包括单次给药和循环给药。
  • COMPOUNDS AND THERAPEUTIC USES
    申请人:Unity Biotechnology, Inc.
    公开号:US20170281649A1
    公开(公告)日:2017-10-05
    Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.
查看更多